FDA Approves First Therapy to Treat Patients with Rare Blood Disorder
WASHINGTON, D.C. — On Friday, the U.S. Food and Drug Administration granted approval to Reblozyl (luspatercept–aamt) for the treatment of anemia (lack of red blood cells) in adult patients with …
Read More